This inventor holds 1 USPTO granted patent. Top assignee: National Research Council of Canada. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Will Costain: Innovator in Therapeutic Compounds
Introduction
Will Costain is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of therapeutic compounds, particularly in relation to the blood-brain barrier. His innovative work aims to address critical medical challenges, including lysosomal storage diseases and α-synucleinopathies.
Latest Patents
Costain holds a patent for "Blood-brain barrier transmigrating therapeutic compounds and uses thereof." This invention involves a compound that comprises an antibody or a fragment capable of crossing the blood-brain barrier (BBB). It also includes a polypeptide related to the treatment of lysosomal storage disease (LSD) and α-synucleinopathies. The patent outlines pharmaceutical compositions and methods for treating these conditions.
Career Highlights
Will Costain is affiliated with the National Research Council of Canada, where he has been instrumental in advancing research in therapeutic applications. His work has garnered attention for its potential impact on treating complex neurological disorders.
Collaborations
Costain has collaborated with esteemed colleagues, including Hung Fang and Danica Stanimirovic. These partnerships have enhanced the scope and depth of his research endeavors.
Conclusion
Will Costain's innovative contributions to therapeutic compounds highlight his commitment to addressing significant medical challenges. His work continues to pave the way for advancements in the treatment of neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile